Supriya Lifescience Limited (SUPRIYA) — Cash Flow-to-Debt Ratio
Supriya Lifescience Limited (SUPRIYA) has a Cash Flow-to-Debt Ratio of 0.46x as of September 2025, meaning its operating cash flow of Rs555.65 Million could theoretically repay 0% of its total liabilities (Rs1.21 Billion) in one year. See SUPRIYA cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Supriya Lifescience Limited Cash Flow-to-Debt Ratio (2018–2025)
Historical debt coverage capacity for Supriya Lifescience Limited across 8 annual periods. Also explore net asset momentum of Supriya Lifescience Limited to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Supriya Lifescience Limited (2018–2025)
Year-by-year debt coverage analysis for Supriya Lifescience Limited. For market capitalisation and broader financial context, see SUPRIYA stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (INR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 1.49x | Rs1.73 Billion | Rs1.16 Billion | ▲ +39.5% |
| 2024 | 1.07x | Rs1.13 Billion | Rs1.06 Billion | ▲ +95.4% |
| 2023 | 0.55x | Rs661.87 Million | Rs1.21 Billion | ▲ +33.7% |
| 2022 | 0.41x | Rs488.01 Million | Rs1.19 Billion | ▼ -9.3% |
| 2021 | 0.45x | Rs799.30 Million | Rs1.77 Billion | ▼ -27.1% |
| 2020 | 0.62x | Rs1.16 Billion | Rs1.87 Billion | ▲ +102.8% |
| 2019 | 0.31x | Rs486.72 Million | Rs1.59 Billion | ▲ +234.0% |
| 2018 | 0.09x | Rs174.52 Million | Rs1.91 Billion | — |